About Us
Sesha Neervannan, Ph.D.
Chief Operating Officer
Sesha has over 25 years of global drug development experience of novel therapeutics. Prior to joining Tarsus, he was a Senior Vice President of Global Pharmaceutical Development at Allergan, where he built strong and nimble early development functions to rapidly enable proof of concept as well as a robust late-stage development organization for product approval and commercialization of small molecules and biologics. He also established an industry-leading expertise in ocular drug delivery technologies. He oversaw and contributed to multiple ocular, oral and dermal product development programs, regulatory filings and approvals, including novel intra-ocular, sustained-release injectables (Ozurdex®, Durysta®), a multidose non-preserved drug product in a novel container-closure delivery system (Restasis® Multidose), topical dermal products (Rhofade® Cream, Aczone® Gel 7.5%) and several Rx and OTC topical ophthalmic products. He is also recognized for inspiring high performing teams, translating strategy into results-driven objectives with a focus on people development.
Prior to joining Allergan in 2007, Sesha was Director, Pharmaceutics R&D, at Amgen Inc., where he oversaw CMC functions and assisted in building pharmaceutics functions, primarily focusing on discovery-development interface to enable pipeline advancement. Early in his career, he was Senior Research Investigator, Pharmaceutics R&D, at Bristol-Myers Squibb, Pharmaceutical Research Institute.
Sesha has a PhD in Pharmaceutical Chemistry, with Honors, from the University of Kansas, and a Bachelor of Science in Pharmacy, with Honors, from Birla Institute of Technology and Science, Pilani, India.